Clinical Application of Wearable Ultrasound Sensors

NCT ID: NCT07009873

Last Updated: 2025-06-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-06-15

Study Completion Date

2026-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to develop and evaluate a wearable ultrasound imaging sensor for the early diagnosis and real-time monitoring of various diseases, such as cardiovascular conditions and structural abnormalities of superficial organs. With advancements in medical technology, wearable devices have attracted increasing attention for their portability and real-time capabilities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

DVT - Deep Vein Thrombosis POCUS

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention.

This study is designed to assess the non-inferiority of a novel ultrasound imaging technique, rather than to evaluate a therapeutic intervention.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 yrs and able to consent
* Relevant diagnosis for study arm (heart failure, lower-limb DVT, or ICU monitoring)
* Adequate acoustic window and intact skin at sensor site

Arm-specific:

* Heart-failure arm: Clinically stable HFrEF or HFpEF on standard therapy
* DVT arm: Imaging-confirmed lower-limb DVT, anticoagulated or scheduled for intervention
* ICU arm: ICU/post-op patient requiring continuous bedside ultrasound

Exclusion Criteria

* Poor acoustic window preventing interpretable images
* Local skin infection, open wound, or implant/hardware blocking sensor
* Inability to cooperate with monitoring

Arm-specific:

* Heart-failure arm: Acute MI or uncontrolled arrhythmia in past 3 months
* DVT arm: Active bleeding or severe coagulopathy
* ICU arm: Unstable multi-organ failure precluding safe monitoring
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese PLA General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Yu-kun Luo

Clinical Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Yukun Luo, Professor, M.D.

Role: PRINCIPAL_INVESTIGATOR

Chinese PLA General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chinese PLA General Hospital

Beijing, Beijing Municipality, China

Site Status

Countries

Review the countries where the study has at least one active or historical site.

China

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Yuyang Li, PhD

Role: CONTACT

+86 18145505119

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Jia Zhang

Role: primary

+86 13262211459

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

S2025-096-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.